These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33958723)

  • 1. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
    Klempnauer KH
    Exp Hematol; 2022 Apr; 108():8-15. PubMed ID: 35032593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
    Klempnauer KH
    Oncotarget; 2023 Mar; 14():174-177. PubMed ID: 36913305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.
    Schmidt TJ; Klempnauer KH
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
    Abdel Ghani L; Yusenko MV; Frank D; Moorthy R; Widen JC; Dörner W; Khandanpour C; Harki DA; Klempnauer KH
    Cancer Lett; 2022 Apr; 530():170-180. PubMed ID: 35077804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
    Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
    Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
    Yusenko MV; Biyanee A; Andersson MK; Radetzki S; von Kries JP; Stenman G; Klempnauer KH
    Cancer Lett; 2021 Nov; 520():132-142. PubMed ID: 34256093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
    Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
    Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
    Elife; 2021 Feb; 10():. PubMed ID: 33527899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
    Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
    J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ.
    Falkenberg KD; Jakobs A; Matern JC; Dörner W; Uttarkar S; Trentmann A; Steinmann S; Coulibaly A; Schomburg C; Mootz HD; Schmidt TJ; Klempnauer KH
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1349-1358. PubMed ID: 28476645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
    Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
    Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction and functional collaboration of p300 and C/EBPbeta.
    Mink S; Haenig B; Klempnauer KH
    Mol Cell Biol; 1997 Nov; 17(11):6609-17. PubMed ID: 9343424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
    Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
    Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.